Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Skin lymphatic vessels are essential for hair growth.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Aging makes hair thinner and rougher, with less clear edges.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Propionibacterium acnes might be linked to hair casts and possibly alopecia.

Proper education can prevent traction alopecia in women of color.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Lupus can cause hair loss and nail changes, with treatments available for both.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Fine wool sheep have more genes for wool quality, while coarse wool sheep have more for skin and muscle traits.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.